10:02 AM EST - Fennec Pharmaceuticals Inc. : Today reported its financial results for the fiscal year ended December 31, 2022. Net losses for the fourth quarter and year ended December 31, 2022 of $6.9 million ($0.26 per share) and $23.7 million ($0.90 per share), respectively, compared to $4.4 million ($0.18 per share) and $17.3 million ($0.67 per share), respectively, for the same periods in 2021. Fennec Pharmaceuticals Inc.
shares T.FRX are trading up $0.75 at $11.15.
